Benazepril Hydrochloride and Hydrochlorothiazide
Active substance: BENAZEPRIL HYDROCHLORIDE, HYDROCHLOROTHIAZIDE
TABLET · BENAZEPRIL HYDROCHLORIDE 20 mg/1, HYDROCHLOROTHIAZIDE 25 mg/1
United StatesActive
Marketing holder: ANI Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- BENAZEPRIL HYDROCHLORIDE · 20 mg/1
- HYDROCHLOROTHIAZIDE · 25 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4fb7-7c7d-8e14-7c141c648bf3,01a1208c-6f20-78e2-9a13-43e14dcccb52,01a1208c-6f92-736b-bc55-eaa24160b218,01a1208c-6fe6-79e5-9b98-d4c4a9343fba,01a1208c-885a-7ebd-b874-fec6ed967089;count=88 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 62559-417
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 62559-417 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 62559-417 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 62559-417 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 62559-417 · Verified 2026-10-09 · open in source